Medicago Inc.

Canadian biopharmaceutical firm Medicago Inc. is to cease all operations and lay off its entire workforce of close to 600, although the detailed schedule for the shut-down is still undecided. The Qu

Medicago and its partner GlaxoSmithKline could be on track to have a Phase III readout for their COVID-19 vaccine candidate by summer, which the Canadian company hopes would also demonstrate the ef

Takeda Contractor Lends Dengue Capacity To Janssen Vaccine Takeda Pharmaceutical Co. Ltd. has entered into an agreement with the German contract development and manufacturing organization IDT Biolog

Moderna Vaccine Ready For Interim Analysis The Phase III study of Moderna, Inc. ’s mRNA vaccine against SARS-CoV-2 has reached the threshold of cases needed to perform the first interim analysis. In